
Research Corporation Technologies (RCT) is a Tucson, Arizona-based technology investment and management firm that provides early-stage venture funding and development for biomedical and life science companies, with technologies originating from universities and research institutions worldwide.
Average disclosed round size is $61.9M (across 7 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Danielle Wilson
Director of Administration & Corporate Secretary
Chad W. Souvignier, Ph.D
Vice President
David A. Wiersma
Senior Associate
Maggie Zhou
Associate Controller
William Kelly
Associate
Christopher P. Martin
President, Medical Devices & Chief Financial Officer
Jorge Figueroa
Systems Administrator
Kathleen M. Hunter-Gregory
Controller
Shaun A. Kirkpatrick
President, Biotechnologies
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $120M | May 2024 | |
| Series A | $68M | Sep 2022 | |
| Series D | $123M | Jan 2018 | |
| Series D | $10M | Sep 2017 | |
| NNatera, Inc. | Unknown | $55.5M | Apr 2015 |
| Unknown | $45M | Jul 2001 | |
| CCyMedica Orthopedics | Series A | $11.5M | — |
Top Co-Investors
Last updated: 9 September 2026